caffeine has been researched along with Cardiomyopathy, Hypertrophic in 4 studies
Cardiomyopathy, Hypertrophic: A form of CARDIAC MUSCLE disease, characterized by left and/or right ventricular hypertrophy (HYPERTROPHY, LEFT VENTRICULAR; HYPERTROPHY, RIGHT VENTRICULAR), frequent asymmetrical involvement of the HEART SEPTUM, and normal or reduced left ventricular volume. Risk factors include HYPERTENSION; AORTIC STENOSIS; and gene MUTATION; (FAMILIAL HYPERTROPHIC CARDIOMYOPATHY).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hallas, T | 1 |
| Eisen, B | 1 |
| Shemer, Y | 1 |
| Ben Jehuda, R | 1 |
| Mekies, LN | 1 |
| Naor, S | 1 |
| Schick, R | 1 |
| Eliyahu, S | 1 |
| Reiter, I | 1 |
| Vlodavsky, E | 1 |
| Katz, YS | 1 |
| Õunap, K | 1 |
| Lorber, A | 1 |
| Rodenburg, R | 1 |
| Mandel, H | 1 |
| Gherghiceanu, M | 1 |
| Binah, O | 1 |
| Jensen, EA | 1 |
| Foglia, EE | 1 |
| Schmidt, B | 1 |
| Landstrom, AP | 1 |
| Kellen, CA | 1 |
| Dixit, SS | 1 |
| van Oort, RJ | 1 |
| Garbino, A | 1 |
| Weisleder, N | 1 |
| Ma, J | 1 |
| Wehrens, XH | 1 |
| Ackerman, MJ | 1 |
| Gwathmey, JK | 1 |
| Warren, SE | 1 |
| Briggs, GM | 1 |
| Copelas, L | 1 |
| Feldman, MD | 1 |
| Phillips, PJ | 1 |
| Callahan, M | 1 |
| Schoen, FJ | 1 |
| Grossman, W | 1 |
| Morgan, JP | 1 |
1 review available for caffeine and Cardiomyopathy, Hypertrophic
| Article | Year |
|---|---|
Evidence-Based Pharmacologic Therapies for Prevention of Bronchopulmonary Dysplasia: Application of the Grading of Recommendations Assessment, Development, and Evaluation Methodology.
Topics: Anti-Bacterial Agents; Azithromycin; Bronchopulmonary Dysplasia; Caffeine; Cardiomyopathy, Hypertrop | 2015 |
3 other studies available for caffeine and Cardiomyopathy, Hypertrophic
| Article | Year |
|---|---|
Investigating the cardiac pathology of SCO2-mediated hypertrophic cardiomyopathy using patients induced pluripotent stem cell-derived cardiomyocytes.
Topics: Action Potentials; Adult; Arrhythmias, Cardiac; Caffeine; Cardiomyopathy, Hypertrophic; Carrier Prot | 2018 |
Junctophilin-2 expression silencing causes cardiocyte hypertrophy and abnormal intracellular calcium-handling.
Topics: Animals; Caffeine; Calcium Channels, L-Type; Calcium Signaling; Cardiomegaly; Cardiomyopathy, Hypert | 2011 |
Diastolic dysfunction in hypertrophic cardiomyopathy. Effect on active force generation during systole.
Topics: Adult; Aged; Caffeine; Calcium; Cardiomyopathy, Hypertrophic; Colforsin; Diastole; Female; Hemodynam | 1991 |